Scholars Central

EditorialPublished 2015

Recent Progresses of Oncolytic Immunotherapy

Authors: Jean-François Fonteneau

Immunotherapy: Open Access

Volume 1 · Issue 1 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Oncolytic immunotherapy, also known as anti-tumor virotherapy, is a therapeutic approach using oncolytic viruses that preferentially or exclusively infect and kill tumor cells. In this short review, we discuss recent advances of this therapeutic strategy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Immunotherapy: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalImmunotherapy: Open Access
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Jean-François Fonteneau”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels